EUVIMEDEUVIMED entdecken
Open Access

Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada

Rajesh Abraham Jacob, Ali Zhang, Hannah O Ajoge, Michael R D'Agostino, Kuganya Nirmalarajah, Altynay Shigayeva, Wael L Demian, Sheridan J C Baker, Hooman Derakhshani, Laura Rossi, Jalees A Nasir, Emily M Panousis und 13 weitere

Emerging Infectious Diseases · 2023

DOI: 10.3201/eid2907.230198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2023. Verfasst von Rajesh Abraham Jacob und 24 weiteren Autor:innen. Hauptthemen laut MEDLINE: Interferon Type I, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Type ICOVID-19HumansSARS-CoV-2Antibodies, NeutralizingCOVID-19 SerotherapyCanadaAntibodies, ViralSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

COVID-19CanadaN501Y spikeSARS-CoV-2VoCVuMcoronavirus diseaseneutralizing antibodiesrespiratory infectionssevere acute respiratory syndrome coronavirus 2type I interferonsvariant under monitoringvariants of concernviruseszoonoses

Substanzen

Interferon Type IAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Förderung

  • CIHR

Zitieren

APA

Jacob, R. A., Zhang, A., Ajoge, H. O., D'Agostino, M. R., Nirmalarajah, K., Shigayeva, A., Demian, W. L., Baker, S. J. C., Derakhshani, H., Rossi, L., Nasir, J. A., Panousis, E. M., Draia, A. N., Vermeiren, C., Gilchrist, J., Smieja, N., Bulir, D., Smieja, M., Surette, M. G., …, & Mossman, K. (2023). Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada. Emerging Infectious Diseases. https://doi.org/10.3201/eid2907.230198

Vancouver

Jacob RA, Zhang A, Ajoge HO, D'Agostino MR, Nirmalarajah K, Shigayeva A, et al. Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada. Emerging Infectious Diseases. 2023. doi:10.3201/eid2907.230198

BibTeX
@article{Jacob2023,
  author = {Jacob, Rajesh Abraham and Zhang, Ali and Ajoge, Hannah O and D'Agostino, Michael R and Nirmalarajah, Kuganya and Shigayeva, Altynay and Demian, Wael L and Baker, Sheridan J C and Derakhshani, Hooman and Rossi, Laura and Nasir, Jalees A and Panousis, Emily M and Draia, Ahmed N and Vermeiren, Christie and Gilchrist, Jodi and Smieja, Nicole and Bulir, David and Smieja, Marek and Surette, Michael G and McArthur, Andrew G and McGeer, Allison J and Mubareka, Samira and Banerjee, Arinjay and Miller, Matthew S and Mossman, Karen},
  title = {Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada},
  journal = {Emerging Infectious Diseases},
  year = {2023},
  doi = {10.3201/eid2907.230198}
}
Kostenlos starten →